Disposition of butadiene epoxides in Sprague-Dawley rats

被引:11
作者
Valentine, JL
Boogaard, PJ
Sweeney, LM
Turner, MJ
Bond, JA
Medinsky, MA
机构
[1] CHEM IND INST TOXICOL,RES TRIANGLE PK,NC 27709
[2] GENZYME CORP,FRAMINGHAM,MA 01701
[3] SHELL INT CHEM BV,DEPT MOL TOXICOL,SHELL RES & TECHNOL CTR,NL-1030 BN AMSTERDAM,NETHERLANDS
[4] CONCURRENT TECHNOL CORP,JOHNSTOWN,PA 15904
关键词
D O I
10.1016/S0009-2797(97)03773-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
1,2-Epoxybutene (BMO) and diepoxybutane (BDE) are metabolic products of 1,3-butadiene in rodents. Both BMO and BDE are suspect in the development of tumors in rats and mice. To understand the distribution and elimination of these compounds in the absence of the rate-limiting production from butadiene, the pharmacokinetics of BMO and BDE in blood were determined in adult male Sprague-Dawley rats following intravenous administration. All animals were dually cannulated in these studies. For the BMO studies, rats were dosed with 71, 143, or 286 mu mol/kg BMO (n = 3 for each dose group). For the BDE studies, rats were dosed with 523 mu mol/kg BDE (n = 3). All animals tolerated the BMO and BDE doses without grossly observable adverse effects. Blood was drawn at predetermined time points and extracted in methylene chloride. BDE and BMO concentrations were quantitated by gas chromatography or gas chromatograpy/mass spectrometry. The BMO distribution half-lives were short and ranged from 1.4 min at the lowest dose to 1.8 min at the highest dose. Volume of distribution at steady state ranged from 0.53 +/- 0.17 to 0.59 +/- 0.31 1/kg. Systemic clearances ranged from 67 +/- 17 to 114 +/- 20 ml/min per kg. The terminal elimination half-lives were also short and ranged from 5.7 to 8.5 min among the doses, The pharmacokinetic parameters after an i.v. dose of 523 mu mol/kg BDE were a distribution half-life of 2.7 min, terminal elimination T-1/2 of 14 min, volume of distribution at steady state of 0.73 +/- 0.06 1/kg, and systemic clearance of 76 +/- 8 ml/min per kg. These pharmacokinetic parameters demonstrate the similarity between disposition of the two epoxides in rats, that include a rapid distribution after i.v. administration into a small extravascular body compartment as well as a rapid elimination from blood. These pharmacokinetic data provide useful blood clearance information for assessing the critical physiological and biochemical determinants underlying the disposition of butadiene epoxides. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:103 / 115
页数:13
相关论文
共 34 条
[1]  
ALTMAN PL, 1961, FEDERATION AM SOC EX, P359
[2]   ANALYSIS OF BUTADIENE, BUTADIENE MONOXIDE, AND BUTADIENE DIOXIDE IN BLOOD BY GAS-CHROMATOGRAPHY GAS-CHROMATOGRAPHY MASS-SPECTROSCOPY [J].
BECHTOLD, WE ;
STRUNK, MR ;
THORNTONMANNING, JR ;
HENDERSON, RF .
CHEMICAL RESEARCH IN TOXICOLOGY, 1995, 8 (02) :182-187
[3]   BIOLOGICAL ACTIVATION OF 1,3-BUTADIENE TO VINYL OXIRANE BY RAT-LIVER MICROSOMES AND EXPIRATION OF THE REACTIVE METABOLITE BY EXPOSED RATS [J].
BOLT, HM ;
SCHMIEDEL, G ;
FILSER, JG ;
ROLZHAUSER, HP ;
LIESER, K ;
WISTUBA, D ;
SCHURIG, V .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1983, 106 (02) :112-116
[4]   SPECIES-DIFFERENCES IN THE DISPOSITION OF INHALED BUTADIENE [J].
BOND, JA ;
DAHL, AR ;
HENDERSON, RF ;
DUTCHER, JS ;
MAUDERLY, JL ;
BIRNBAUM, LS .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1986, 84 (03) :617-627
[5]   The role of hydrolysis in the detoxification of 1,2:3,4-diepoxybutane by human, rat, and mouse liver and lung in vitro [J].
Boogaard, PJ ;
Bond, JA .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1996, 141 (02) :617-627
[6]   STATISTICAL ESTIMATIONS IN PHARMACOKINETICS [J].
BOXENBAU.HG ;
RIEGELMA.S ;
ELASHOFF, RM .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1974, 2 (02) :123-148
[7]   METABOLIC CAGE ISOLATION REDUCES ANTIPYRINE CLEARANCE IN RATS [J].
BRUNNER, LJ ;
DIPIRO, JT ;
FELDMAN, S .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1994, 46 (07) :581-584
[8]   MUTAGENICITY OF BUTADIENE AND ITS EPOXIDE METABOLITES .2. MUTATIONAL SPECTRA OF BUTADIENE, 1,2-EPOXYBUTENE AND DIEPOXYBUTANE AT THE HPRT LOCUS IN SPLENIC T-CELLS FROM EXPOSED B6C3F1 MICE [J].
COCHRANE, JE ;
SKOPEK, TR .
CARCINOGENESIS, 1994, 15 (04) :719-723
[9]   MUTAGENICITY OF BUTADIENE AND ITS EPOXIDE METABOLITES .1. MUTAGENIC POTENTIAL OF 1,2-EPOXYBUTENE, 1,2,3,4-DIEPOXYBUTANE AND 3,4-EPOXY-1,2-BUTANEDIOL IN CULTURED HUMAN LYMPHOBLASTS [J].
COCHRANE, JE ;
SKOPEK, TR .
CARCINOGENESIS, 1994, 15 (04) :713-717
[10]   COMPARISON OF THE BIOTRANSFORMATION OF 1,3-BUTADIENE AND ITS METABOLITE, BUTADIENE MONOEPOXIDE, BY HEPATIC AND PULMONARY TISSUES FROM HUMANS, RATS AND MICE [J].
CSANADY, GA ;
GUENGERICH, FP ;
BOND, JA .
CARCINOGENESIS, 1992, 13 (07) :1143-1153